Company Filing History:
Years Active: 2018
Title: Baowei Li: Innovator in Cancer Treatment
Introduction
Baowei Li is a prominent inventor based in Beijing, China. He has made significant contributions to the field of cancer research, particularly through his innovative work on monoclonal antibodies.
Latest Patents
Li holds a patent for a monoclonal antibody against the human PrPc protein. This antibody is capable of reducing the expression level of the transcription factor Twist1 in a targeted manner. It also induces macrophage and NK cells to target rectal cancer tumor cells. Notably, the combined drug therapy using this antibody along with cetuximab demonstrates a more effective inhibitory effect on tumors compared to administering either treatment alone.
Career Highlights
Baowei Li is affiliated with the Chinese Academy of Sciences, where he conducts his research. His work has garnered attention for its potential to improve cancer treatment outcomes.
Collaborations
Li collaborates with notable colleagues, including Quan Chen and Haiying Hang, who contribute to his research endeavors.
Conclusion
Baowei Li's innovative work in developing monoclonal antibodies represents a significant advancement in cancer therapy. His contributions have the potential to enhance treatment efficacy and improve patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.